Description
Paliris XR 1.5mg: Essential Guide to Uses, Dosage & Price in Pakistan
What is Paliris XR 1.5mg?
Paliris XR 1.5mg is an atypical antipsychotic medicine containing paliperidone, which is used in the treatment of certain psychiatric conditions.
Paliperidone works by affecting the activity of dopamine and serotonin, two important chemical messengers in the brain. These chemicals help regulate thinking, emotions, perception, and behaviour.
The medicine helps reduce certain symptoms associated with schizophrenia and schizoaffective disorder.
The letters XR stand for extended release. This means the tablet is designed to release its active ingredient gradually over time.
Paliris XR 1.5mg is a lower-strength tablet that may be selected when a psychiatrist needs an individualized dosing plan. It is not the usual FDA-recommended starting dose for schizophrenia or schizoaffective disorder.
The medicine helps control symptoms but does not permanently cure these conditions.
Product Information
- Product Name: Paliris XR 1.5mg
- Generic Name: Paliperidone
- Composition: Paliperidone 1.5mg per tablet
- Dosage Form: Extended-release oral tablet
- Medicine Category: Atypical antipsychotic
- Pack Size: 10 tablets
- Manufacturer: Cell Laboratories (Pvt.) Ltd.
- Main Uses: Schizophrenia and schizoaffective disorder
- Prescription Status: Prescription medicine
For additional manufacturer information, visit the Cell Laboratories Paliris XR product page.
Uses & Benefits of Paliris XR 1.5mg
Paliris XR 1.5mg contains paliperidone, an antipsychotic medicine prescribed for certain conditions that affect thoughts, emotions, and behaviour.
1. Helps Manage Schizophrenia
Schizophrenia can affect how a person thinks, communicates, and understands reality.
People with schizophrenia may experience symptoms that interfere with relationships, work, education, or everyday activities.
Paliperidone may help manage:
- Hearing voices that other people cannot hear
- Seeing things that are not present
- Strongly held false beliefs
- Confused or disorganized thinking
- Excessive suspiciousness
- Disturbed behaviour
- Difficulty managing everyday activities because of psychotic symptoms
Paliris XR 1.5mg may be used as part of a psychiatrist’s individualized treatment plan. The correct dose depends on the patient’s clinical needs.
2. Helps Control Symptoms of Schizoaffective Disorder
Schizoaffective disorder is a psychiatric condition that includes symptoms of psychosis along with significant mood episodes.
Patients may experience hallucinations or delusions together with episodes of depression or mania.
Paliperidone may help manage psychotic symptoms associated with schizoaffective disorder.
In adults, paliperidone extended-release tablets may be prescribed alone or alongside certain mood stabilizers or antidepressants when clinically appropriate.
Paliris XR 1.5mg should only be used in the dosage selected by the treating psychiatrist.
3. Supports Ongoing Psychiatric Symptom Management
Schizophrenia often requires continued treatment to maintain symptom control.
Some patients may need long-term antipsychotic treatment to reduce the risk of symptoms returning.
Paliperidone extended-release tablets have been studied for ongoing management of schizophrenia.
However, Paliris XR 1.5mg should not be assumed to provide the same clinical response as higher strengths. Its suitability depends on the prescribed dose and the patient’s condition.
4. Provides Extended-Release Administration
Paliris XR 1.5mg uses an extended-release formulation designed to release paliperidone gradually.
Paliperidone XR tablets are generally administered once daily, depending on the prescription.
The tablet must remain intact to preserve its release characteristics.
These uses are consistent with FDA prescribing information for paliperidone extended-release tablets.
Who Can Take Paliris XR 1.5mg?
Paliris XR 1.5mg may be prescribed to selected patients with psychiatric conditions requiring paliperidone treatment.
Adults With Schizophrenia
Adults diagnosed with schizophrenia may receive paliperidone to help manage hallucinations, delusions, disorganized thinking, and other psychotic symptoms.
The psychiatrist determines the appropriate dose according to the patient’s condition and response.
Adults With Schizoaffective Disorder
Paliperidone may be prescribed for adults experiencing symptoms of schizoaffective disorder.
Treatment may involve paliperidone alone or, when appropriate, alongside other psychiatric medicines.
Adolescents With Schizophrenia
FDA prescribing information recognizes paliperidone extended-release treatment for schizophrenia in adolescents aged 12–17 years.
However, the usual FDA-recommended starting dose is 3mg daily, and dose selection depends partly on body weight.
Paliris XR 1.5mg should therefore not be considered a standard starting treatment for adolescents without specific specialist instructions.
Patients Requiring Individualized Dosing
Some patients may require careful dose adjustments because of medical conditions, previous side effects, or other treatment-related factors.
Kidney function is particularly important because paliperidone is mainly eliminated through the kidneys.
The 1.5mg strength may offer a lower-dose option, but the physician must determine whether it is appropriate.
These age groups and indications are based on FDA information for paliperidone. They do not independently confirm that every FDA indication is approved for the Paliris XR brand in Pakistan.
How to Use / Dosage
Paliris XR 1.5mg must be taken exactly as prescribed by a qualified psychiatrist or registered medical practitioner.
The appropriate dose depends on the patient’s diagnosis, age, kidney function, treatment response, and other medicines.
General Dosage Information
According to FDA prescribing information for paliperidone extended-release tablets:
- Adult schizophrenia: The usual recommended starting dose is 6mg once daily.
- Adult schizophrenia treatment range: Generally 3–12mg daily.
- Adult schizoaffective disorder: The usual recommended starting dose is 6mg once daily.
- Adult schizoaffective disorder treatment range: Generally 3–12mg daily.
- Adolescent schizophrenia: The usual recommended starting dose is 3mg once daily, with the recommended maximum depending on body weight.
Important: The 1.5mg strength is lower than the usual FDA-recommended starting doses for these conditions.
A psychiatrist may consider different dosing in certain clinical circumstances, but patients should never start or adjust Paliris XR 1.5mg themselves.
Patients with kidney impairment require special dosing assessment. Some patients may need lower doses or different schedules, while use is not recommended in severe impairment below certain kidney-function thresholds.
How to Take Paliris XR 1.5mg Safely
- Take the tablet according to the prescribed schedule.
- Swallow it whole with water.
- It may generally be taken with or without food.
- Do not chew the tablet.
- Do not crush or break the tablet.
- Do not take more than the prescribed amount.
- Avoid alcohol during treatment.
- Do not double a forgotten dose.
- Do not stop treatment without medical advice.
- Attend regular psychiatric follow-up appointments.
Why Should Paliris XR 1.5mg Not Be Crushed?
Paliris XR 1.5mg is an extended-release medicine.
Its formulation is designed to control the release of the active ingredient over time.
Crushing, chewing, or splitting an extended-release tablet can interfere with the way the medicine is delivered.
Always swallow the tablet whole unless the manufacturer provides different specific instructions.
How Does Paliris XR 1.5mg Work?
Paliris XR 1.5mg contains paliperidone, which mainly acts on dopamine D2 and serotonin 5-HT2A receptors.
Dopamine is involved in thinking, motivation, movement, and perception.
Serotonin contributes to mood regulation and other brain functions.
By blocking certain receptors, paliperidone helps regulate signalling involved in psychotic symptoms.
This action may help reduce hallucinations, delusions, unusual thinking, and some behavioural disturbances.
The time needed for improvement varies between patients. Some symptoms may begin improving earlier than others, while a fuller response can take several weeks.
Regular follow-up helps the psychiatrist determine whether the treatment is working appropriately.
Price in Pakistan
Price in Pakistan: PKR 450.00
The provided price of Paliris XR 1.5mg is PKR 450.00 for a pack of 10 tablets.
The actual retail price may vary depending on the pharmacy, city, product availability, or future manufacturer price changes.
Precautions & Side Effects
Important Precautions
Before taking Paliris XR 1.5mg, patients should inform their psychiatrist about existing medical conditions and other medicines they are using.
Extra medical care may be needed in patients with:
- Kidney disease
- Diabetes or high blood sugar
- Heart disease
- Irregular heartbeat
- Low blood pressure
- High cholesterol
- Epilepsy or a history of seizures
- Parkinson’s disease
- Previous abnormal body movements
- High prolactin levels
- Difficulty swallowing
- Significant gastrointestinal narrowing or obstruction
- Pregnancy or breastfeeding
- Allergies to paliperidone or risperidone
Paliperidone may affect heart rhythm in susceptible patients. Doctors should review conditions and medicines that increase the risk of QT prolongation.
Patients should also tell their doctor if they are taking risperidone or another antipsychotic, because combining psychiatric medicines may increase certain risks.
Common Side Effects
Possible side effects of Paliris XR 1.5mg and paliperidone treatment include:
- Headache
- Dizziness
- Sleepiness
- Restlessness
- Difficulty sitting still (akathisia)
- Tremor
- Muscle stiffness
- Fast heartbeat
- Constipation
- Nausea
- Increased appetite or weight changes
- Low blood pressure when standing
Paliperidone can also increase prolactin levels, which may lead to menstrual changes, breast-related symptoms, or sexual difficulties.
Not all patients experience these side effects, and the likelihood may vary with dose and individual factors.
Serious Side Effects
Seek urgent medical attention if a patient taking Paliris XR 1.5mg develops:
- High fever with severe muscle stiffness and confusion
- Uncontrolled movements of the face, tongue, or body
- Fainting or severe changes in heartbeat
- Seizures
- Serious allergic reactions
- Severe changes in blood sugar
- Significant changes in consciousness
- A painful erection lasting several hours
These symptoms may indicate serious reactions requiring immediate medical assessment.
Important Warning for Elderly Patients
Paliris XR 1.5mg is not approved for treating dementia-related psychosis in elderly patients.
FDA prescribing information warns that antipsychotic medicines can increase the risk of death in elderly patients with dementia-related psychosis.
Why Is Kidney Function Important During Treatment?
Paliperidone is mainly removed from the body through the kidneys.
If a patient’s kidneys are not working properly, more medicine may remain in the bloodstream.
For this reason, doctors may check kidney function before selecting a dose of Paliris XR 1.5mg or another paliperidone strength.
The dose may need to be adjusted according to the patient’s kidney-function results.
Patients should never decide their own dose based only on the available tablet strength.
Monitoring During Paliris XR 1.5mg Treatment
Regular psychiatric appointments are important during treatment with Paliris XR 1.5mg.
Depending on the patient’s condition, the doctor may monitor:
- Improvement in psychiatric symptoms
- Mood and behaviour
- Kidney function
- Body weight
- Blood glucose
- Cholesterol levels
- Blood pressure
- Heart-related symptoms
- Restlessness or abnormal movements
- Prolactin-related symptoms
- Overall treatment response
Regular monitoring helps the psychiatrist assess the benefits and possible risks of treatment.
Storage Instructions
Store Paliris XR 1.5mg according to the instructions printed on the original packaging.
General recommendations include:
- Keep the tablets in their original blister packaging.
- Store in a cool, dry place.
- Protect from excessive heat and moisture.
- Keep away from direct sunlight.
- Keep out of the reach of children.
- Do not use after the printed expiry date.
Medicine Safety in Pakistan
Paliris XR 1.5mg should only be used on the prescription of a qualified psychiatrist or registered medical practitioner.
Patients in Pakistan should purchase prescription medicines from reliable pharmacies and follow their doctor’s treatment instructions.
The Drug Regulatory Authority of Pakistan (DRAP) operates the National Pharmacovigilance Centre to monitor suspected adverse reactions associated with medicines.
Patients, caregivers, pharmacists, and healthcare professionals can report suspected medicine-related side effects through DRAP’s official reporting services.
For more information:
Frequently Asked Questions (FAQs)
What is the price of Paliris XR 1.5mg in Pakistan?
The listed Paliris XR 1.5mg price in Pakistan is PKR 450.00 for a pack of 10 tablets. Retail prices may vary between pharmacies and locations.
What are the uses of Paliris XR 1.5mg?
Paliris XR 1.5mg contains paliperidone, an atypical antipsychotic used for schizophrenia and schizoaffective disorder. It helps manage hallucinations, delusions, confused thinking, and other psychotic symptoms when prescribed appropriately.
Is Paliris XR 1.5mg used for schizophrenia?
Yes. Paliris XR 1.5mg contains paliperidone, which is used in the treatment of schizophrenia. However, 1.5mg is below the usual FDA-recommended starting dose, so the psychiatrist must decide whether this strength is appropriate.
Can Paliris XR 1.5mg be crushed or divided?
No. Paliris XR 1.5mg is an extended-release tablet and should be swallowed whole. Crushing, chewing, or splitting it can interfere with the intended release of the medicine.
Important Medical Notice
Paliris XR 1.5mg is a prescription psychiatric medicine and must only be used under the supervision of a qualified psychiatrist or registered medical practitioner.
This information is intended for patients and caregivers in Pakistan and does not replace professional medical advice, diagnosis, or treatment.
FDA prescribing information relates to paliperidone as an active ingredient and does not independently confirm that every FDA indication is locally approved for the Paliris XR brand.
The XR tablets described here are oral extended-release tablets and are not the same as long-acting injectable paliperidone treatments.
Do not start, stop, increase, reduce, crush, or divide Paliris XR 1.5mg without professional medical advice.
